Margaret Hamburg, M.D.
Co-president, InterAcademy Partnership
Margaret A. Hamburg, MD, Joins NTI as Interim Vice President for NTI | bio
NTI board member Margaret A. Hamburg, MD, is joining NTI’s leadership to serve as interim vice president of the NTI | bio program in February. Hamburg, an internationally recognized leader in public health and medicine, replaces Beth Cameron, PhD, who has moved to the White House to rebuild the National Security Council’s Office of Global Health Security and Biodefense and advance the Biden Administration’s agenda on global health security.
Hamburg’s relationship with NTI goes back to its launch in 2001, when she was named as the organization’s founding senior scientist and biological program vice president. She went on to become commissioner of the Food and Drug Administration and foreign secretary of the National Academy of Medicine.
Hamburg joined NTI’s Board of Directors in 2017.
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
More News
NTI | bio Engages Global Leaders at GHS2026 in Kuala Lumpur
NTI | bio experts will take part in several GHS2026 sessions, including a preview of findings from the forthcoming Africa Health Security (AHS) Index and a timely discussion on strengthening health security partnerships amid declining resources.
Applications Open: Strengthening Biosecurity & Pandemic Preparedness Through Intergenerational Dialogue
As breakthroughs in artificial intelligence and biotechnology outpace global governance, the Nuclear Threat Initiative (NTI) and The Elders are launching a new intergenerational initiative to generate the ideas and leadership needed for a safer future against biological threats.
NTI Horizon Scan Helps Leaders Anticipate Fast‑Moving AIxBio Advances
With AIxBio tools advancing faster than many experts predicted, new AIxBio Horizon Scan provides early insights to support stronger safety, security, and governance decisions.
